Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer’s disease
Abstract Background Tau pathology biomarkers provide prognostic indicators of neurodegeneration and cognitive decline in Alzheimer’s disease (AD), making them crucial to early patient stratification for disease-modifying interventions. Plasma p-tau217 indexes early tau pathophysiology, whereas FDA/E...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-06-01
|
| coleção: | Alzheimer’s Research & Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13195-026-02123-3 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|